Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a Two-Hour class boost HPV smarts? new study aims to find out

NCT ID NCT07231263

First seen Nov 17, 2025 · Last updated Jun 23, 2026 · Updated 27 times

Summary

This study will test whether a two-hour educational session can increase women's knowledge about HPV, the virus that causes cervical cancer. Researchers will enroll 110 women in Turkey, split into an education group and a control group. Knowledge will be measured before and after the training using a standard questionnaire.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS (HPV) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

HPV awareness education program (two 1-hour sessions with PowerPoint and brochure)

What this could lead to

If successful, this could show that a simple, low-cost education program significantly improves women's understanding of HPV and its prevention.

What could go wrong

This is a small, early-stage study with only 110 women in one city, so results may not apply to other groups. Knowledge gains may not lead to actual behavior change.

Conditions

The condition(s) this trial relates to.

human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.